Akinori Ueda
Stock Analyst at Goldman Sachs
(3.12)
# 2,572
Out of 5,023 analysts
50
Total ratings
56.2%
Success rate
6.5%
Average return
Main Sectors:
Stocks Rated by Akinori Ueda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TYO: 4528 Ono Pharmaceutical Co., Ltd. | Reiterated: Sell | ¥2,200 | ¥2,290 | -3.93% | 1 | Aug 14, 2026 | |
| TYO: 6869 Sysmex Corporation | Reiterated: Buy | ¥2,000 → ¥1,950 | ¥1,819 | +7.23% | 3 | Aug 10, 2026 | |
| TYO: 7733 Olympus Corporation | Reiterated: Hold | ¥2,050 → ¥2,300 | ¥1,958 | +17.47% | 6 | Aug 10, 2026 | |
| TYO: 2413 M3, Inc. | Reiterated: Hold | ¥1,850 → ¥1,750 | ¥1,753 | -0.17% | 6 | Aug 7, 2026 | |
| TYO: 4507 Shionogi & Co., Ltd. | Upgraded: Buy | ¥3,300 → ¥3,400 | ¥2,786 | +22.04% | 2 | Jun 15, 2026 | |
| TYO: 4519 Chugai Pharmaceutical Co., Ltd. | Upgraded: Buy | ¥8,950 | ¥6,032 | +48.38% | 3 | Jun 15, 2026 | |
| LINK Interlink Electronics | Reiterated: Buy | n/a | $5.95 | - | 1 | Jun 15, 2026 | |
| TYO: 4578 Otsuka Holdings Co., Ltd. | Reiterated: Buy | ¥11,900 → ¥12,400 | ¥11,320 | +9.54% | 9 | Apr 30, 2026 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Rated: Buy | ¥4,900 → ¥4,300 | ¥2,709 | +58.73% | 3 | Apr 15, 2026 | |
| TYO: 4587 PeptiDream Inc. | Reiterated: Buy | ¥3,000 → ¥2,750 | ¥1,076 | +155.58% | 4 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | ¥2,500 → ¥2,250 | ¥2,230 | +0.90% | 4 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $41.75 | n/a | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | ¥3,700 | ¥5,643 | n/a | 1 | Jan 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ¥5,000 | ¥2,244 | n/a | 1 | Dec 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4,700.00 | n/a | 1 | Jun 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.86 | n/a | 2 | Apr 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $12.40 | n/a | 1 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2,245.00 | n/a | 1 | Jun 8, 2018 |
Ono Pharmaceutical Co., Ltd.
Aug 14, 2026
Reiterated: Sell
Price Target: ¥2,200
Current: ¥2,290
Upside: -3.93%
Sysmex Corporation
Aug 10, 2026
Reiterated: Buy
Price Target: ¥2,000 → ¥1,950
Current: ¥1,819
Upside: +7.23%
Olympus Corporation
Aug 10, 2026
Reiterated: Hold
Price Target: ¥2,050 → ¥2,300
Current: ¥1,958
Upside: +17.47%
M3, Inc.
Aug 7, 2026
Reiterated: Hold
Price Target: ¥1,850 → ¥1,750
Current: ¥1,753
Upside: -0.17%
Shionogi & Co., Ltd.
Jun 15, 2026
Upgraded: Buy
Price Target: ¥3,300 → ¥3,400
Current: ¥2,786
Upside: +22.04%
Chugai Pharmaceutical Co., Ltd.
Jun 15, 2026
Upgraded: Buy
Price Target: ¥8,950
Current: ¥6,032
Upside: +48.38%
Interlink Electronics
Jun 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.95
Upside: -
Otsuka Holdings Co., Ltd.
Apr 30, 2026
Reiterated: Buy
Price Target: ¥11,900 → ¥12,400
Current: ¥11,320
Upside: +9.54%
Daiichi Sankyo Company, Limited
Apr 15, 2026
Rated: Buy
Price Target: ¥4,900 → ¥4,300
Current: ¥2,709
Upside: +58.73%
PeptiDream Inc.
Feb 17, 2026
Reiterated: Buy
Price Target: ¥3,000 → ¥2,750
Current: ¥1,076
Upside: +155.58%
Dec 16, 2025
Downgraded: Sell
Price Target: ¥2,500 → ¥2,250
Current: ¥2,230
Upside: +0.90%
Jul 19, 2023
Reiterated: Buy
Price Target: $40
Current: $41.75
Upside: n/a
Jan 13, 2022
Downgraded: Hold
Price Target: ¥3,700
Current: ¥5,643
Upside: n/a
Dec 21, 2021
Reiterated: Hold
Price Target: ¥5,000
Current: ¥2,244
Upside: n/a
Jun 16, 2021
Reiterated: Hold
Price Target: n/a
Current: $4,700.00
Upside: n/a
Apr 19, 2021
Reiterated: Buy
Price Target: n/a
Current: $17.86
Upside: n/a
Dec 20, 2018
Upgraded: Buy
Price Target: n/a
Current: $12.40
Upside: n/a
Jun 8, 2018
Downgraded: Hold
Price Target: n/a
Current: $2,245.00
Upside: n/a